Oxygen Therapy – Action, Indications, Benefits

Oxygen therapy, clinically referred to as *oxygenation therapy*, constitutes a specialized medical intervention centered on delivering to the patient a respiratory gas mixture with an elevated concentration of molecular oxygen (exceeding 90% by volume). The primary clinical indications for its implementation include states of diminished blood oxygenation—termed *hypoxemia*—as well as scenarios characterized by impaired pulmonary ventilation or complete respiratory failure. Depending on the patient’s degree of autonomy and level of consciousness, two core therapeutic modalities are distinguished: **passive oxygen therapy**, which necessitates the patient’s active participation in the ventilatory process (often administered in outpatient settings as *long-term home oxygen therapy*), and **active oxygen therapy**, designed for individuals incapable of spontaneous breathing or those in an unconscious state (e.g., coma), thereby mandating inpatient care. An additional classification criterion pertains to the oxygen delivery regimen—it may be administered **intermittently** (in cyclic sessions tailored to individual requirements) or **continuously** (24-hour supplementation), with the selection contingent upon the dynamics of respiratory parameters and the patient’s overall clinical presentation.

Normobaric oxygen therapy constitutes an advanced respiratory support modality that employs a meticulously balanced gaseous mixture, diverging significantly from conventional oxygen therapy protocols. Whereas traditional oxygen administration delivers concentrations of approximately 90% O₂, this variant maintains an oxygen fraction of roughly 40%, supplemented by controlled admixtures of up to 3% carbon dioxide (CO₂) and 0.5% molecular hydrogen (H₂). A defining characteristic of the procedure is its execution under atmospheric pressure conditions not exceeding 1500 hectopascals, thereby obviating the need for hyperbaric chambers. Treatments are conducted within purpose-built, sealed environments, with session durations adaptable to individual patient requirements—free from rigid time constraints.

The hyperbaric approach is distinguished by its unique method of oxygen administration. Throughout the therapeutic procedure, the patient is exposed to an environment composed solely of pure oxygen at full saturation—specifically 100% concentration—entirely devoid of any gaseous contaminants. The individual undergoing treatment is positioned within a sealed, specialized enclosure constructed from high-grade materials such as reinforced steel or transparent acrylic polymer, commonly referred to as a "hyperbaric chamber." Within this apparatus, a precisely regulated atmospheric pressure is maintained, ranging between 1300 and 1500 hectopascals. The typical duration of a single therapeutic session generally spans from sixty to one hundred twenty minutes, contingent upon individualized medical recommendations and the established treatment protocol.

Historically, oxygen therapy relied on pressurized oxygen cylinders, which in some instances are still utilized within hospital settings. However, the use of these cylinders is associated with a multitude of limitations and hazards, leading to a gradual shift toward more advanced solutions. Foremost among the drawbacks is the necessity for frequent replacement once the cylinder is depleted, which incurs ongoing costs and logistical challenges. Additionally, storing high-pressure oxygen tanks poses significant safety risks—even minor structural defects can result in catastrophic explosions, necessitating strict storage protocols, typically in outdoor, well-ventilated areas away from residential spaces and heat sources. This presents substantial difficulties, particularly for elderly, disabled, or solitary individuals who may struggle with the independent management of such equipment. Furthermore, precise adjustment of oxygen flow rates when using cylinders often requires the intervention of trained medical personnel, such as community nurses, thereby limiting patient autonomy. In contemporary practice, oxygen concentrators have emerged as the predominant method for oxygen therapy, offering a far more practical and secure alternative. These devices are characterized by their user-friendly and largely automated operation. Their mechanism involves drawing in ambient air and filtering it to enhance oxygen concentration, thereby eliminating the need for cylinder replacement. As a result, concentrators can be used virtually anywhere, and the oxygen supply remains uninterrupted. Their operation requires only distilled water, which ensures proper humidification and purity of the generated airflow. Crucially, these devices pose no risk of explosion, making them significantly safer for home use. Oxygen concentrators provide multiple operational modes, including continuous and pulsed oxygen delivery, and are available in two primary configurations: stationary units, designed for patients with limited mobility, such as those recovering from surgery, and portable models, powered by batteries or rechargeable cells, which are ideal for ambulatory individuals requiring oxygen therapy during daily activities like walking or shopping. In contrast, active oxygen therapy, exclusively administered in hospital settings, relies on ventilators. Oxygen is delivered to patients via a nasal cannula—commonly referred to as "oxygen prongs"—or through specialized oxygen masks that enable controlled gas administration.

The acquisition of a new home oxygen therapy device represents a substantial financial burden, frequently amounting to several thousand dollars. While purchasing second-hand equipment may serve as a cost-effective alternative, it inherently carries an elevated risk of technical malfunctions and reduced operational lifespan. In specific clinical scenarios, reimbursement through national healthcare programs may be available—provided that stringent medical criteria are met, including an exceptionally low oxygen saturation level (< 55 mmHg), which typically correlates with severe hypoxemia or advanced-stage chronic obstructive pulmonary disease (COPD). It is important to note, however, that not all patients will qualify for such reimbursement schemes, and the application process may necessitate comprehensive medical documentation to substantiate eligibility.

Inhalation of oxygen-enriched air or the administration of 100% medical-grade oxygen exerts a well-documented, beneficial impact on the human body. Primarily, this intervention leads to a substantial enhancement of hemoglobin oxygen saturation levels (SpO₂), which in turn optimizes blood gas metrics. The augmented delivery of oxygen to cells, tissues, and internal organs initiates a cascade of physiological responses, including: reinforcement of immune defense mechanisms, mitigation of inflammatory conditions of diverse etiologies, enhancement of cardiopulmonary efficiency, neutralization of the deleterious effects of reactive oxygen species (free radicals), reduction of both oxidative and psychological stress, improvement in sleep architecture and emotional equilibrium, stimulation of dermal microcirculation (thereby accelerating epidermal regeneration and wound healing), and modulation of cellular metabolism, which may contribute to the normalization of biochemical markers—such as blood glucose concentrations and lipid profiles (including low-density and high-density lipoprotein cholesterol levels).

There is overwhelming consensus that oxygen administration represents a cornerstone therapeutic intervention primarily intended for patients experiencing respiratory system dysfunctions. The decision to initiate oxygen therapy is fundamentally grounded in abnormal arterial blood gas analysis findings, with hemoglobin saturation falling below the 94% threshold serving as an absolute criterion for implementing non-invasive ventilatory support techniques. Long-term home oxygen therapy is medically justified across a broad spectrum of pulmonary conditions, encompassing chronic obstructive pulmonary disease (COPD), bronchial asthma, bronchiectasis, idiopathic pulmonary fibrosis, cystic fibrosis, and post-traumatic or postoperative states. Hyperbaric oxygen therapy demonstrates particular efficacy in cases of acute poisoning with toxic gases such as carbon monoxide. Notably, the benefits of oxygen therapy extend beyond conventional pulmonological indications—encompassing migraine symptom alleviation, sleep disorder management, hypoxia-related dermatological conditions, and adjunctive support for neurological rehabilitation (e.g., post-stroke recovery) or metabolic therapies (e.g., type 2 diabetes mellitus or dyslipidemia). Both normobaric and hyperbaric oxygen therapies also serve preventive medicine purposes in healthy individuals—as a strategy to mitigate respiratory system degeneration caused by exposure to urban air pollution or as a component of occupational stress management protocols. Furthermore, these therapeutic modalities are routinely incorporated into elite athletes' physiological recovery regimens to accelerate tissue repair processes and optimize overall physical performance.

While oxygen therapy represents a non-invasive and generally safe modality for respiratory support with well-documented clinical benefits, its application is not universally appropriate and carries distinct contraindications that must be rigorously observed. Primary exclusions include a history of thoracic surgical interventions—particularly procedures involving the pleural cavity—as well as untreated pneumothorax in the absence of chest tube drainage. Additionally, acute upper respiratory tract infections accompanied by febrile states constitute an absolute prohibition. Of equal importance is the avoidance of oxygen administration during pharmacotherapy with specific agents, notably bleomycin (due to its pulmonary toxicity profile) and disulfiram (which may precipitate disulfiram-like reactions). Absolute contraindications further extend to poisoning by highly toxic compounds such as paraquat or chemical warfare agents, where oxygen exposure risks exacerbating tissue damage. Heightened caution is mandated for high-risk populations, including pregnant women, individuals with implanted cardiac pacemakers, oncology patients (given the potential for accelerated tumor angiogenesis), and those diagnosed with optic neuritis or a susceptibility to seizure activity—whether induced by antiepileptic medications or underlying epilepsy. Under both normobaric and hyperbaric conditions, claustrophobia may present a significant limitation, as confinement within an oxygen chamber can trigger panic attacks; in such instances, portable oxygen concentrators offer a viable therapeutic substitute. It is equally critical to emphasize that excessive and medically unjustified oxygen supplementation in normoxic individuals may precipitate adverse outcomes. Prolonged inhalation of gas mixtures with oxygen concentrations exceeding 50% at normal saturation levels poses a substantial risk of respiratory epithelium injury, potentially culminating in bronchitis, tracheitis, or even toxic pneumonitis.